EP1377254A2 - Preparations cosmetiques et dermatologiques contenant des isoflavones - Google Patents

Preparations cosmetiques et dermatologiques contenant des isoflavones

Info

Publication number
EP1377254A2
EP1377254A2 EP02727450A EP02727450A EP1377254A2 EP 1377254 A2 EP1377254 A2 EP 1377254A2 EP 02727450 A EP02727450 A EP 02727450A EP 02727450 A EP02727450 A EP 02727450A EP 1377254 A2 EP1377254 A2 EP 1377254A2
Authority
EP
European Patent Office
Prior art keywords
weight
och
sebum
isoflavones
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02727450A
Other languages
German (de)
English (en)
Inventor
Stefan Gallinat
Kirsten Venzke
Andreas Herpens
Helga Biergiesser
Franz STÄB
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of EP1377254A2 publication Critical patent/EP1377254A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair

Definitions

  • Cosmetic and dermatological preparations containing isoflavones and use of isoflavones for the production of cosmetic and dermatological preparations for reducing the sebum content of the skin are also included.
  • the excessive secretion of the sebaceous glands can be triggered by, among other things, androgenetic disorders and has an aesthetic disadvantage on the Velvet image of the hair This disorder can also be the cause of hair loss.
  • the precursor is the seborrhoeic condition of the scalp. Vegetative disorders and improper care can worsen the complexion and the condition of the hair. Even with seborrhea, the hair itself can be dry due to disorders in the build-up of keratin Dry, damaged hair is often caused by external stress such as the sun or chemical treatments. Too hot blow drying or improper care of damaged hair can lead to damage
  • the causes of oily hair are in the human body and are caused by hormones.
  • Each hair has its own sebum gland, which produces fat (sebum, sebum).
  • Sebum production is hormonally controlled and, depending on the hormone sensitivity of the sebum gland, it can cause an overuse - or come underproduction
  • the sebum itself has the function of keeping the scalp supple. It reaches the scalp from the sebaceous gland and only later the hairline. There it is normally absorbed by the hair shaft and remains invisible Able to take it in. It is visible as a greasy film on the hair
  • the active ingredients are preferably used in cosmetic or dermatological compositions with a content of 0.0005-50.0% by weight, in particular 0.01-20.0% by weight, based on the total weight of the composition.
  • the compositions advantageously contain 0 , 02-10.0% by weight, particularly preferably 0.02-5.0% by weight of the active ingredients used according to the invention, very particularly advantageously 0.5-3.0% by weight, in each case based on the total weight of the composition
  • polymers for example in particles based on highly crosslinked polymethacre ylates and / or cellulose acetates and / or as core / shell particles with Particles with a shell made of poly (oxymethylurea), nylon, polyamides, polyurethane, polyester, gelatin and polyolefins
  • the UVB filters can be oil-soluble or water-soluble.
  • oil-soluble substances e.g. to name: 3-benzylidene camphor and its derivatives, e.g. 3- (4-methylbenzylidene) camphor,
  • 4-aminobenzoic acid derivatives preferably 4- (dimethylamino) benzoic acid
  • the cosmetic and dermatological preparations used according to the invention can contain cosmetic active ingredients, auxiliaries and / or additives as are usually used in such preparations, e.g. antioxidants, preservatives, bactericides, perfumes, substances for preventing foaming, dyes, pigments have a coloring effect, thickeners, surface-active substances, emulsifiers, softening, moisturizing and / or moisturizing Substances, fats, oils, waxes or other usual components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives
  • hydrocarbons paraffinol, squalane and squalene can advantageously be used for the purposes of the present invention

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation d'isoflavones pour produire des préparations destinées à réduire la production de sébum et/ou à établir une homéostasie de sébum normale, ainsi que pour la prévention et le traitement des cheveux gras et des pellicules.
EP02727450A 2001-03-23 2002-03-21 Preparations cosmetiques et dermatologiques contenant des isoflavones Withdrawn EP1377254A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10114305 2001-03-23
DE10114305A DE10114305A1 (de) 2001-03-23 2001-03-23 Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Isoflavonen und Verwendung von Isoflavonen zur Herstellung kosmetischer und dermatologischer Zubereitungen zur Reduktion des Sebumgehaltes der Haut
PCT/EP2002/003162 WO2002076409A2 (fr) 2001-03-23 2002-03-21 Preparations cosmetiques et dermatologiques contenant des isoflavones et utilisation d'isoflavones pour produire des preparations cosmetiques et dermatologiques destinees a reduire le taux de sebum de la peau

Publications (1)

Publication Number Publication Date
EP1377254A2 true EP1377254A2 (fr) 2004-01-07

Family

ID=7678731

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02727450A Withdrawn EP1377254A2 (fr) 2001-03-23 2002-03-21 Preparations cosmetiques et dermatologiques contenant des isoflavones

Country Status (4)

Country Link
US (1) US20040170655A1 (fr)
EP (1) EP1377254A2 (fr)
DE (1) DE10114305A1 (fr)
WO (1) WO2002076409A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10121375B4 (de) * 2001-05-02 2014-01-16 Beiersdorf Ag Verwendung von Isoflavonoiden in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut
DE10211192A1 (de) * 2002-03-14 2003-09-25 Beiersdorf Ag Isoflavanoide gegen Hautalterung und Akne
DE10301631A1 (de) * 2003-01-17 2004-07-29 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Sojabohnenkeimextrakten in Kombination mit Vitamin C und/oder E sowie alpha-Glycosylrutin
DE102004020712A1 (de) * 2004-04-27 2005-11-24 Beiersdorf Ag Kosmetische Kapseln
BRPI0612848B8 (pt) * 2005-06-29 2021-05-25 Dsm Ip Assets Bv composição de nanopartículas de isoflavona, processo para a produção da mesma e seu uso, composição farmacêutica, composição cosmética, e produto nutricional
FR2897778B1 (fr) * 2006-02-28 2012-12-14 Limousine D Applic Biolog Ditesilab Soc Ind Procede d'obtention d'un actif cosmetique pour ameliorer l'etat des peaux a tendance grasse et/ou acneique, principe actif obtenu et compositions associees
DE102013104441A1 (de) * 2013-04-30 2014-10-16 Bodo C. Melnik Akne-Medikament und Verfahren zu seiner Herstellung
CN115915970A (zh) * 2020-06-15 2023-04-04 国立大学法人东海国立大学机构 白发抑制剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085788B2 (ja) * 1987-10-08 1996-01-24 花王株式会社 ５α−リダクターゼ阻害剤
JPH02193919A (ja) * 1989-01-23 1990-07-31 Kao Corp 皮脂線抑制剤
DE4432947C2 (de) * 1994-09-16 1998-04-09 New Standard Gmbh Mittel zur Behandlung der Haut und seine Verwendung
JPH09157156A (ja) * 1995-12-01 1997-06-17 Kikkoman Corp 入浴剤
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
JPH10226642A (ja) * 1997-02-18 1998-08-25 Kikkoman Corp 皮膚増殖疾患の治療剤
US6051602A (en) * 1998-03-16 2000-04-18 The Procter & Gamble Company Methods for regulating skin appearance
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
DE19845324A1 (de) * 1998-10-01 2000-04-06 Beiersdorf Ag Verwendung von Nitrilotriessigsäure zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und Nitrilessigsäure sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
DE19845266A1 (de) * 1998-10-01 2000-04-06 Beiersdorf Ag Verwendung von Butylhydroxytoluol zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und Butylhydroxytoluol sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
DE19845319A1 (de) * 1998-10-01 2000-04-06 Beiersdorf Ag Verwendung von oberflächenaktiven Substanzen zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und oberflächenaktiven Substanzen sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
DE19845322A1 (de) * 1998-10-01 2000-04-06 Beiersdorf Ag Verwendung von 2-tert.-Butylhydrochinon zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und 2-tert.-Butylhydrochinon sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
DE19904352C1 (de) * 1999-02-03 2000-08-10 Indena Spa Lipide enthaltender Soja-Extrakt, Verfahren zu dessen Herstellung und pharmazeutische bzw. kosmetische Zusammensetzung sowie deren Verwendung zur Prävention oder Behandlung von trockener Haut
FR2803747B1 (fr) * 2000-01-18 2003-12-26 Pharmascience Lab Utilisation d'isoflavones et/ou d'extraits de prunier d'afrique en pharmacie, cosmetique et en tant qu'additif alimentaire.
FR2811562B1 (fr) * 2000-07-13 2003-03-07 Oreal Composition, notamment cosmetique, renfermant la dhea et un isoflavonoide
EP1234572B1 (fr) * 2001-02-26 2013-10-30 Mibelle AG Cosmetics Produits de soin pour la peau contenant de l'isoflavone aglycone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO02076409A2 *

Also Published As

Publication number Publication date
WO2002076409A3 (fr) 2003-04-24
DE10114305A1 (de) 2002-09-26
WO2002076409A2 (fr) 2002-10-03
US20040170655A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
EP1642559B1 (fr) Utilisation de créatine et/ou de dérivés de créatine et de l'acide folique dans des préparations cosmétiques ou dermatologiques
EP0945126B1 (fr) Composition cosmétique ou dermatologique contenant de la carnitine et/ou un acylcarnitine et au moins un antioxydant
WO1996018379A1 (fr) Preparations cosmetiques et dermatologiques aux flavonoïdes
EP1594455B1 (fr) Preparations cosmetiques ou dermatologiques contenant de la creatine, de la creatinine et / ou leurs derives en combinaison avec des extraits de germe de graines de soja
EP1623698A1 (fr) Utilisation d'une combinaison comprenant au moins un bioquinone et au moins un isoflavanoïde pour améliorer l'état de la peau
EP1172084A2 (fr) Composition cosmétique et dermatologique pour éliminer du sébum
DE10132338A1 (de) Verwendung von 5'-Desoxy-5'-methylthioadenosin in hautkosmetischen Mitteln
EP1179338A1 (fr) Compositions cosmétiques et dermatologiques comprenant des cyclodextrines pour enlever le sebum
DE19720339A1 (de) Wirkstoffe und Zubereitungen für die Hautaufhellung und zur Verhinderung der Hautbräunung
WO2002076409A2 (fr) Preparations cosmetiques et dermatologiques contenant des isoflavones et utilisation d'isoflavones pour produire des preparations cosmetiques et dermatologiques destinees a reduire le taux de sebum de la peau
EP1733741A2 (fr) Emulsion H/E contenant un ou plusieurs bioquinones et un teneur de glycerine élevée
WO2003011241A1 (fr) Utilisation de creatinine et/ou de derives de la creatinine dans des preparations cosmetiques ou dermatologiques
WO2005030157A1 (fr) Preparations cosmetiques ou dermatologiques a teneur en isoflavones et en licochalcone a
EP1000603B1 (fr) Utilisation d'esters tensioactifs d'acide citrique pour stabiliser de flavones, flavanones ou de flavonoides et mélanges synergiques, compositions cosmétiques et dermatologiques les contenant
DE19806946A1 (de) Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
WO2002098386A2 (fr) Utilisation de polystyrene sulfonate de sodium pour raffermir la peau
EP1383473A2 (fr) Preparations cosmetiques et dermatologiques renfermant un extrait de houblon ou de houblon-malt et leur utilisation pour la reduction de la secretion de sebum cutane
DE29924371U1 (de) O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin
DE10121069A1 (de) Verwendung von Tetrahydrocurcuminoiden oder deren Derivaten als Wirkstoffe zur Herstellung von kosmetischen und dermatologischen Zubereitungen zum Schutz und zur Behandlung der trockenen bzw. alterstrockenen Haut
DE102004006829A1 (de) Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Isoflavonen und Antitranspirantwirkstoffen, sowie die Verwendung von Isoflavonen und Antitranspirantwirkstoffen zur Herstellung kosmetischer und dermatologischer Zubereitungen zur Bekämpfung von Sebum
DE102017210389A1 (de) Kosmetische Zubereitungen mit einem Gehalt an einer oder mehreren alpha-Hydroxycarbonsäuren und/oder einer oder mehreren beta-Hydroxycarbonsäuren und/oder einer oder mehreren Polyhydroxysäuren, einem oder mehreren Distearaten und Stärke
DE10048261A1 (de) Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Pyridoxamin zur Hautaufhellung von Altersflecken und/oder zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung
DE19739044A1 (de) Verwendung von Dihydrorobinetin als Antioxidans oder Radikalfänger in kosmetischen oder dermatologischen Zubereitungen
DE19845266A1 (de) Verwendung von Butylhydroxytoluol zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und Butylhydroxytoluol sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
DE10121067A1 (de) Kombination von Tetrahydrocurcuminoiden oder deren Derivaten mit 3-[4-Hydroxyphenylsulfatester]-2-Aminopropionsäure oder 3-[3-Hydroxyphenylsulfatester]-2-Aminopropionsäure (Tyrosin O-Sulfatester) oder entsprechende Sulfonsäureester oder Phosphatester oder ihre Derivate sowie ihre pflanzlichen und tierischen Extrakte als Wirkstoffe zur Herstellung von kosmetischen und dermatologischen Zubereitungen zur Haufaufhellung oder zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20031024

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061109